.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080028

« Back to Dashboard
NDA 080028 describes BLEPH-30, which is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. Additional details are available on the BLEPH-30 profile page.

The generic ingredient in BLEPH-30 is sulfacetamide sodium. There are three drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.

Summary for NDA: 080028

Tradename:
BLEPH-10
Applicant:
Allergan
Ingredient:
sulfacetamide sodium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 080028

Ingredient-typeSulfonamides

Suppliers and Packaging for NDA: 080028

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BLEPH-10
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC 080028 NDA Allergan, Inc. 11980-011 11980-011-05 1 BOTTLE, PLASTIC in 1 CARTON (11980-011-05) > 5 mL in 1 BOTTLE, PLASTIC
BLEPH-10
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC 080028 ANDA Pacific Pharma 60758-018 60758-018-05 1 BOTTLE, DROPPER in 1 CARTON (60758-018-05) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength10%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength30%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc